IMW 2019 | Myeloma: why PROMISE?

Annie Cowan

Annie Cowan, BA, Dana-Farber Cancer Institute, Boston, MA, outlines the aims, methods and results of the PROMISE study (NCT03689595), at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video